Learn more about a current clinical trial that Brain Matters Research is involved in. Dr. Brody says,

Learn more about a current clinical trial that Brain Matters Research is involved in. Dr. Brody says,

“This documentary is a MUST-SEE. Brain Matters Research is on a mission to end Alzheimer’s Disease..."



PBS Special Report
One of the largest, most respected private clinical research facilities in the country specializing in Alzheimer's Disease diagnosis, treatment and prevention.

One of the largest, most respected private clinical research facilities in the country specializing in Alzheimer's Disease diagnosis, treatment and prevention.


Join our next trial.
Become a part of the Brain Matters family and receive the best disease-modifying medications that are currently being researched.

Become a part of the Brain Matters family and receive the best disease-modifying medications that are currently being researched.


Find the right clinical trial.
Encouragement.  Assistance.  Resources.  Education.
We specialize in Central Nervous System (CNS) trials, with an emphasis on Alzheimer’s Disease, for which we are recognized as one of the leading top-tier sites in North America.

We specialize in Central Nervous System (CNS) trials, with an emphasis on Alzheimer’s Disease, for which we are recognized as one of the leading top-tier sites in North America.


Contact us.
Patients receive initial assessments, memory testing and examination at no cost.

Patients receive initial assessments, memory testing and examination at no cost.

We care about you and your quality of life.



Be a participant.

 

Knowledge of increased risk for CANCER compels patients to take action…..they make impactful treatment decisions, seek out renowned specialists, and enter clinical trials. Waiting idly wouldn’t be an option.

Our mission is to elevate Alzheimer’s disease to that level of urgency. It is a degenerative “cancer of the brain” that no one survives. Brain Matters Research is on a mission, and we need community involvement……those diagnosed with Alzheimer’s, those at risk for the disease, those concerned they might be having symptoms, and those willing to participate in the research process.

Doing nothing is no longer an option.

Mark Brody MD, CPI
Founder, Principal Investigator
Brain Matters Research